Terapi Opioid pada Kasus COVID-19

  • Akhmad Yun Jufan Departemen Anestesiologi dan Terapi Intensif, Fakultas Kedokteran, Kesehatan Masyarakat, dan Keperawatan, Universitas Gadjah Mada, Yogyakarta, Indonesia
  • Juni Kurniawaty Departemen Anestesiologi dan Terapi Intensif, Fakultas Kedokteran, Kesehatan Masyarakat, dan Keperawatan, Universitas Gadjah Mada, Yogyakarta, Indonesia
  • Baiq Dessy Resmana Dewi Departemen Anestesiologi dan Terapi Intensif, Fakultas Kedokteran, Kesehatan Masyarakat, dan Keperawatan, Universitas Gadjah Mada, Yogyakarta, Indonesia
Keywords: COVID-19, myalgia, opioid, pain

Abstract

One-third of COVID-19 patients experience a variety of neurological symptoms involving the central and peripheral nervous systems. These symptoms include headache, dizziness, loss of consciousness, impaired smell, neuralgia, and skeletal muscle damage. Myalgia is the most common symptom in cases of COVID-19. Therefore, adequate pain management is
needed, one of the choices is using opioids. Opioid receptor agonists are a group of drugs that stimulate opioid receptors and produce their effects by mimicking endogenous opioid peptides known as endorphins.

Published
2023-06-10
How to Cite
Jufan, A. Y., Kurniawaty, J., & Dewi, B. D. R. (2023). Terapi Opioid pada Kasus COVID-19. Jurnal Komplikasi Anestesi, 9(1), 66-76. https://doi.org/10.22146/jka.v9i1.8515

Most read articles by the same author(s)

<< < 1 2 3 4